[SaneVax: According to The Financial Times, only 32% of young women in the United States eligible to take Gardasil are completing the series. According to Merck, the FDA and the CDC this has nothing to do with the fact that Gardasil is associated with 66.3% of all deaths and 81.2% of all permanent disabilities reported to VAERS in the same cohort since Gardasil was approved for use. Can you imagine the potential consequences if the uptake were greater?]
Merck’s Gardasil, GSK’s Cervarix HPV vaccines see poor adherence, experts question overall response
By Juliana Wexler
Merck’s Gardasil, a human papillomavirus (HPV) vaccine, has poor adherence and more data is required on the effects of receiving fewer than the full three-dose regimen, according to experts interviewed by BioPharm Insight.
A recent Centers for Disease Control and Prevention (CDC) report indicated only 32% of US females aged 13 to 17 received all three doses of an HPV vaccine in 2010. GlaxoSmithKline’s Cervarix is the other marketed HPV vaccine and is also administered as a three-dose regimen.
HPV is a sexually transmitted infection spread via skin that can lead to genital warts or cancers of the genitals or anus. Almost all cases of cervical cancers are caused by HPV, although 90% of HPV infections clear on their own. HPV vaccines prevent infection against the specific HPV genotypes included in the vaccine.
While Gardasil and Cervarix are both approved for use in females, Gardasil is also approved for use in males. The overarching reason to vaccinate males is to prevent them from transmitting HPV to females, an investigator on Merck’s HPV vaccines said.
To further its reach in HPV, Merck is developing another vaccine, V503, which protects against five more cancer-causing HPV genotypes than the two in Gardasil and Cervarix.
Read the entire article here.
As a consequence of aggressive marketing, lobbying and “strong connections” between the Norwegian health authorities and Merck, Gardasil was introduced into the childrens’ vaccination program in Norway. The National Inst of Public Health reports that the number of vaccinated girls is increasing.
70% of girls born in 1997 have had at least one dose. 65% have had all three doses.
79% of girls born in 1998 have had at least one dose. 70 % have had all three doses.
72% of girls born in 1999 have up to now had at least one dose.
Girls are lined up in the classrooms and told to take the vaccine so that they will not get cervical cancer, that it is safe and that all the other girls are getting the vaccine.
The same few people in the same instances in the health authorities are responsible for contact with vaccine manufacturers, ordering of vaccines, information and promotion of vaccines to the public and media, (under)-registration of adverse events and presenting (manipulated) adverse event statistics to the public.
Is this acceptable? Is it acceptable that the Norwegian prime minister is a friend of Bill Gates and contributes millions of tax payers’ money to GAVI? Is it acceptable that the prime minister’s sister is head of the semi-official Norwegian Public Health Institute and is responsible for procurement of vaccines for the Norwegian population? Is it acceptable that the institute receives funds from Rockefeller and that its finances are confidential?
Robin Berenson says
There is a member of my family who is in her 20’s. When she was 19 her gynecologist suggested she get the 3 Gardisal shots. Last year she turned up being HPV positive. I know she was seeing her doctor for several years prior to the shots and had never had a positive test until 2 years after those shots. The doctor says 99% of women who have a positive test.are negative within 2 years. I can’t help but wonder if this was caused by the vaccine.